Cargando…
Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is currently the dominant variant globally. This third interim analysis of a living systematic review summarizes evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effe...
Autores principales: | Külper-Schiek, Wiebe, Piechotta, Vanessa, Pilic, Antonia, Batke, Madeleine, Dreveton, Léa-Sophie, Geurts, Brogan, Koch, Judith, Köppe, Stefan, Treskova, Marina, Vygen-Bonnet, Sabine, Waize, Maria, Wichmann, Ole, Harder, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449804/ https://www.ncbi.nlm.nih.gov/pubmed/36091023 http://dx.doi.org/10.3389/fimmu.2022.940562 |
Ejemplares similares
-
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
por: Harder, Thomas, et al.
Publicado: (2021) -
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
por: Harder, Thomas, et al.
Publicado: (2021) -
Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
por: Harder, Thomas, et al.
Publicado: (2021) -
A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
por: Waize, M, et al.
Publicado: (2022) -
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
por: Treskova-Schwarzbach, Marina, et al.
Publicado: (2021)